✦ LIBER ✦

Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer

✍ Scribed by Elise N. Everett; Amy E. French; Rebecca L. Stone; Lisa M. Pastore; Amir A. Jazaeri; Willie A. Andersen; Peyton T. Taylor Jr.

Book ID: 113430853
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 216 KB
Volume: 195
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2006.03.075

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of Neoadjuvant Chemotherapy (NACT)

Role of Neoadjuvant Chemotherapy (NACT) Followed by Surgical Cytoreduction in Advanced Epithelial Ovarian Cancer

✍ Sonia Batra, Himanshu Nayak, Kalpna S. Dave 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 335 KB

Predictors of suboptimal surgical cytore

Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer

✍ Elise N. Everett; Cara C. Heuser; Lisa M. Pastore; Willie A. Anderson; Laurel W. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Demethylation of the MCJ gene in stage I

Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy

✍ Gordon Strathdee; J. Keith Vass; Karin A. Oien; Nadeem Siddiqui; Jorge Curto-Gar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Systematic Review of First-Line Chemothe

Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer

✍ Allan Covens; Mark Carey; Peter Bryson; Shailendra Verma; Michael Fung Kee Fung; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 69 KB

The clinical predictivity of biomarkers

The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol

✍ Rosella Silvestrini; Maria Grazia Daidone; Silvia Veneroni; Elvira Benini; Giova 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

GST-p were generally unrelated to one another and unrelated to clinicopathologic features, except for an association between DNA ploidy and the rate of cell prolifer-1 Oncologia Sperimentale C, Istituto Nazionale ation. All biologic variables except bcl-2 were slightly related to tumor grade. DNA pe

Treatment of Stages II, III and IV prima

Treatment of Stages II, III and IV primary surface epithelial ovarian cancers by maximum bulk tumour reduction and combined chemotherapy with cyclophosphamide, doxorubicin and cisplatin

✍ S. Khanna; P. Kirwan; N.J. Naftalin; R.J. Aukett 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 433 KB